Furthermore, since both the LOX and COX pathways were implicated in the development of precancerous colonic polyps, the use of such broad-spectrum LOX and COX inhibitors together with the activation of 15-LOX may be valuable in the chemoprevention of colitis-associated colon cancer. This evidence concerns the gene LOX and intestinal disorder.